A new policy that recommends offering hepatitis B vaccine at birth only to babies perceived to be at risk will lead to ...

The drugmaker Erasca said results on its experimental pill in a trial of pancreatic cancer and non-small cell lung cancer ...

Kennedy broke his pledge to share a controversial contract, highlighting Democrats' frustrations with the health secretary.

The Supreme Court seemed divided Monday over whether to block thousands of lawsuits alleging the maker of the weedkiller ...

The Trump administration underlines a “clear shift away from harm reduction and practices” that it says facilitates illegal ...

The thinking about what risk Covid poses — or doesn't pose — has shifted in recent years. What does it mean for you?

Fewer than half of papers published by NIH-funded researchers analyze or report their data by sex, a new study found.

Veradermics' hair loss pill late-stage trial success, FDA fast-tracks reviews for psychedelics, and more biotech news ...

As a medical student and researcher, I was shocked by the brazen inequity of the trial.  Randomized controlled trials have ...

FDA approved a request from Motif Neurotech, to start an initial feasibility trial to test a brain implant to treat ...

The company is one of the most advanced players in the hair loss field, which has seen a surge of investor enthusiasm.

Legal agreements that directly shape access to care remain invisible to the very people whose lives they govern.